Table 2.

Baseline characteristics of study cohorts

ControlCoV-AKI-RRT
ParameterAll (n=51)All (n=52)≥1 ShortenedNo Shortened
SLED Run (n=44)SLED Run (n=8)
Age (yr)63 (33–88)60 (39–81)58 (39–80)71 (62–81)a
Sex (%)
 Men34 (67)42 (79)35 (80)5 (62)
 Women17 (33)11 (21)9 (20)3 (38)
Race (%)
 Black14 (27)37 (71)b33 (75)4 (50)
 White34 (67)13 (25)b10 (23)3 (38)
 Hispanic2 (4)2 (4)1 (2)1 (13)
 Asian1 (2)000
BMI (kg/m2)32 (20–53)38 (24–67)b39 (24–67)33 (29–40)c
DM17 (33%)27 (52%)24 (55%)3 (38%)
CKD20 (39%)18 (35%)14 (32%)4 (50%)
HTN32 (63%)42 (81%)37 (84%)4 (50%)c
  • Data are presented as n (%), except for age and BMI [median (range)]. CoV-AKI-RRT, patients with coronavirus disease 2019 who developed AKI requiring RRT; SLED, sustained low efficiency dialysis; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension.

  • a P<0.01 versus ≥1 shortened run group.

  • b P<0.001 versus control.

  • c P<0.05 versus ≥1 shortened run group.